Mousumi Pal
Research Subjects
Research Interests
Mousumi Pal has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Jyotirmoy Chatterjee
School of Medical Science and Technology, Indian Institute of Technology, Kharagpur, West Bengal, India
2 shared publications - Ranjan Rashmi Paul
Gurunanak Institute of Dental Science and Research, Department of Oral and Maxillofacial Pathology, Kolkata, West Bengal 700 114, India
2 shared publications Ajoy Kumar Ray
Centre for Healthcare Science and Technology, Indian Institute of Engineering Science and Technology, Shibpur, India
1 shared publication- Amit Basak
Department of Chemistry
1 shared publication - Amit Kumar Das
Department of Bioscience and Biotechnology, Indian Institute of Technology Kharagpur
1 shared publication - Amrita Chaudhary
R&D Infrastructure Division, Department of Science & Technology, New Delhi, India
1 shared publication
Latest Publications
- Open Access
- 10 July 2024
- Published by International Scientific Invention Journals in International Journal of Innovative Research in Medical Science
- Vol. 9 (07) , 408-414
A Brief Review on Immunology of Dental Caries and Caries Vaccine
Dental caries is an irreversible microbial disease of the calcified tissues of the teeth, characterized by demineralization of the inorganic portion and destruction of the organic substance of the tooth, which often leads to cavitation. Untreated dental caries in deciduous teeth was the tenth most widespread and the fourth most expensive chronic illness to treat condition among children worldwide, with prevalence peaking at the age of six. Individuals with active caries have an elevated serum antibody level for mutans streptococci. Findings also suggest that an increased antigenic load (bacteria from lesions) will give rise to elevated salivary antibody. Subjects with selective IgA deficiency without salivary antibody show markedly elevated levels of dental caries when compared to normal controls. IgA deficient subjects with IgM compensatory antibodies have significantly less caries than simply IgA deficient subjects. The immune system in secretions have been used to interfere with caries by stimulating salivary antibodies to appropriate antigens. The gingival crevicular fluid contributes IgG, which can also interfere with caries. This review article emphasizes the comprehensive and contemporary idea about immunological aspect of dental caries along with overview on dental caries and immunity and recent advancements in the field of caries vaccine.
- 10 July 2024
- Published by International Scientific Invention Journals in International Journal of Innovative Research in Medical Science
- Vol. 9 (07) , 408-414
Open AccessA Brief Review on Immunology of Dental Caries and Caries Vaccine
Dental caries is an irreversible microbial disease of the calcified tissues of the teeth, characterized by demineralization of the inorganic portion and destruction of the organic substance of the tooth, which often leads to cavitation. Untreated dental caries in deciduous teeth was the tenth most widespread and the fourth most expensive chronic illness to treat condition among children worldwide, with prevalence peaking at the age of six. Individuals with active caries have an elevated serum antibody level for mutans streptococci. Findings also suggest that an increased antigenic load (bacteria from lesions) will give rise to elevated salivary antibody. Subjects with selective IgA deficiency without salivary antibody show markedly elevated levels of dental caries when compared to normal controls. IgA deficient subjects with IgM compensatory antibodies have significantly less caries than simply IgA deficient subjects. The immune system in secretions have been used to interfere with caries by stimulating salivary antibodies to appropriate antigens. The gingival crevicular fluid contributes IgG, which can also interfere with caries. This review article emphasizes the comprehensive and contemporary idea about immunological aspect of dental caries along with overview on dental caries and immunity and recent advancements in the field of caries vaccine.
- 18 August 2017
- Published by BMJ in Journal of Clinical Pathology
- Vol. 71 (3) , 228-238
Identification of α-enolase as a prognostic and diagnostic precancer biomarker in oral submucous fibrosis
Aims Diagnostic ambiguities regarding the malignant potentiality of oral submucous fibrosis (OSF), an oral precancerous condition having dysplastic and non-dysplastic isoforms are the major failure for early intervention of oral squamous cell carcinoma (OSCC) patients. Our goal is to identify proteomic signatures from biopsies that can be used as precancer diagnostic marker for patient suffering from OSF. Methods The high throughput techniques adopting de novo peptide sequencing (1D SDS-PAGE coupled nanoLC MALDI tandem mass spectrometry (MS/MS)-based peptide mass fingerprint), immunohistochemistry (IHC), Western blot (WB) and real-time PCR (RT-PCR) analysis are considered for such biomarker identification and multilevel validations. Results Alpha-enolase is identified as an overexpressed protein in biopsies of oral submucous fibrosis with dysplasia (OSFWD) compared with oral submucous fibrosis without dysplasia (OSFWT) and normal oral mucosa (NOM). Total proteome analysis of an overexpressed protein band around 47 kDa of OSFWD identifies 334 peptides corresponding to 61 human proteins. Among them α-enolase is identified as a prime protein with highest number of peptides (44 out of 334 peptides) and sequence coverage (66.4%). Furthermore, RT-PCR, WB and IHC analysis also show mRNA and tissue level upregulation of α-enolase in OSFWD validating α-enolase as precancer marker. Conclusions This study for the first time identifies and validates α-enolase as a novel biomarker for early diagnosis of malignant potentiality of OSF. Hence, the identified protein marker, α-enolase can help in early therapeutic intervention of OSF patients leading to the reduction of patient’s pain, treatment cost and enhancement of patient’s quality of life.
- 18 August 2017
- Published by BMJ in Journal of Clinical Pathology
- Vol. 71 (3) , 228-238
Identification of α-enolase as a prognostic and diagnostic precancer biomarker in oral submucous fibrosis
Aims Diagnostic ambiguities regarding the malignant potentiality of oral submucous fibrosis (OSF), an oral precancerous condition having dysplastic and non-dysplastic isoforms are the major failure for early intervention of oral squamous cell carcinoma (OSCC) patients. Our goal is to identify proteomic signatures from biopsies that can be used as precancer diagnostic marker for patient suffering from OSF. Methods The high throughput techniques adopting de novo peptide sequencing (1D SDS-PAGE coupled nanoLC MALDI tandem mass spectrometry (MS/MS)-based peptide mass fingerprint), immunohistochemistry (IHC), Western blot (WB) and real-time PCR (RT-PCR) analysis are considered for such biomarker identification and multilevel validations. Results Alpha-enolase is identified as an overexpressed protein in biopsies of oral submucous fibrosis with dysplasia (OSFWD) compared with oral submucous fibrosis without dysplasia (OSFWT) and normal oral mucosa (NOM). Total proteome analysis of an overexpressed protein band around 47 kDa of OSFWD identifies 334 peptides corresponding to 61 human proteins. Among them α-enolase is identified as a prime protein with highest number of peptides (44 out of 334 peptides) and sequence coverage (66.4%). Furthermore, RT-PCR, WB and IHC analysis also show mRNA and tissue level upregulation of α-enolase in OSFWD validating α-enolase as precancer marker. Conclusions This study for the first time identifies and validates α-enolase as a novel biomarker for early diagnosis of malignant potentiality of OSF. Hence, the identified protein marker, α-enolase can help in early therapeutic intervention of OSF patients leading to the reduction of patient’s pain, treatment cost and enhancement of patient’s quality of life.
- 2 August 2016
- Published by American Chemical Society (ACS) in ACS Biomaterials Science & Engineering
- Vol. 2 (9) , 1528-1539
Differential Behavior of Normal and Fibrotic Fibroblasts under the Synergistic Influence of Micropillar Topography and the Rigidity of Honey/Silk-Fibroin Substrates
We report differential proliferation behavior of normal and fibrosis associated human oral fibroblasts on micropillar honey embedded silk fibroin substrates (HSF). Oral fibroblasts of different origins manifest differences in proliferation rate, morphology, and the cytoskeletal arrangement on HSF substrates with distinct topography (H, D, and S), stiffness, and honey concentration. It is observed that the proliferation rate is maximized for normal and inhibited for fibrosis associated fibroblasts on a HSF substrate surface with moderate height of ∼8.5 μm and 2% honey concentration. Molecular expression analysis reveals decrease in c-myc and p53 expression in later cells validating the inhibition of their proliferation rate, which is further correlated with the decreased Col I and Col III expression on this substrate. A substrate with enhanced interspacing and intermediate mechanical stiffness (0.57 ± 0.32 μN/nm) favors strong adhesion and stable cell–matrix interaction for normal cells, while exhibiting negative influence on fibrotic fibroblasts with poor adhesion and spreading capability. Decrease in vimentin, fibronectin expression, and cytoskeleton reorganization justify the poor stability of later cells on the optimized substrate, thereby allowing selective modulation of normal and fibrosis associated fibroblasts under the synergistic influence of honey concentration, topography, and rigidity of HSF substrates. The work highlights the possible therapeutic efficacy of honey based micropatterned substrates as smart patches for fast wound healing and in minimizing the chances of recurrence of precancer post oral tumor resection surgeries.
- 2 August 2016
- Published by American Chemical Society (ACS) in ACS Biomaterials Science & Engineering
- Vol. 2 (9) , 1528-1539
Differential Behavior of Normal and Fibrotic Fibroblasts under the Synergistic Influence of Micropillar Topography and the Rigidity of Honey/Silk-Fibroin Substrates
We report differential proliferation behavior of normal and fibrosis associated human oral fibroblasts on micropillar honey embedded silk fibroin substrates (HSF). Oral fibroblasts of different origins manifest differences in proliferation rate, morphology, and the cytoskeletal arrangement on HSF substrates with distinct topography (H, D, and S), stiffness, and honey concentration. It is observed that the proliferation rate is maximized for normal and inhibited for fibrosis associated fibroblasts on a HSF substrate surface with moderate height of ∼8.5 μm and 2% honey concentration. Molecular expression analysis reveals decrease in c-myc and p53 expression in later cells validating the inhibition of their proliferation rate, which is further correlated with the decreased Col I and Col III expression on this substrate. A substrate with enhanced interspacing and intermediate mechanical stiffness (0.57 ± 0.32 μN/nm) favors strong adhesion and stable cell–matrix interaction for normal cells, while exhibiting negative influence on fibrotic fibroblasts with poor adhesion and spreading capability. Decrease in vimentin, fibronectin expression, and cytoskeleton reorganization justify the poor stability of later cells on the optimized substrate, thereby allowing selective modulation of normal and fibrosis associated fibroblasts under the synergistic influence of honey concentration, topography, and rigidity of HSF substrates. The work highlights the possible therapeutic efficacy of honey based micropatterned substrates as smart patches for fast wound healing and in minimizing the chances of recurrence of precancer post oral tumor resection surgeries.